Literature DB >> 6196103

Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatin.

R M York, D H Lawson, J McKay.   

Abstract

Twenty-five patients with metastatic melanoma were treated with Velban, bleomycin by infusion, and cisplatin. Of 20 evaluable patients, there were no objective responses. Side effects and toxicity were severe.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6196103     DOI： 10.1002/1097-0142(19831215)52:12<2220::aid-cncr2820521208>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Systemic chemotherapy for malignant melanoma.

Authors:  A S Coates
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

Review 2.  Cisplatin: a review of clinical applications and renal toxicity.

Authors:  D T Sleijfer; S Meijer; N H Mulder
Journal:  Pharm Weekbl Sci       Date:  1985-12-13

3.  Recombinant interferon alpha-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients.

Authors:  I G Ron; M J Inbar; M Gutman; O Merimsky; S Chaitchik
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

4.  Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.

Authors:  D Pectasides; H Yianniotis; N Alevizakos; D Bafaloukos; V Barbounis; J Varthalitis; M Dimitriadis; A Athanassiou
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.